Export 5 results:
Author Title Type [ Year(Asc)]
Filters: Author is Eller, Michael A  [Clear All Filters]
2019
A. Letizia, Eller, M. A., Polyak, C., Eller, L. Anne, Creegan, M., Dawson, P., Bryant, C., D, K., Crowell, T. A., Lombardi, K., Rono, E., Robb, M. L., Michael, N. L., Maswai, J., and Ake, J. A., Biomarkers of Inflammation Correlate With Clinical Scoring Indices in Human Immunodeficiency Virus-Infected Kenyans., J Infect Dis, vol. 219, no. 2, pp. 284-294, 2019.
T. A. Crowell, Colby, D. J., Pinyakorn, S., Sacdalan, C., Pagliuzza, A., Intasan, J., Benjapornpong, K., Tangnaree, K., Chomchey, N., Kroon, E., de Souza, M. S., Tovanabutra, S., Rolland, M., Eller, M. A., Paquin-Proulx, D., Bolton, D. L., Tokarev, A., Thomas, R., Takata, H., Trautmann, L., Krebs, S. J., Modjarrad, K., McDermott, A. B., Bailer, R. T., Doria-Rose, N., Patel, B., Gorelick, R. J., Fullmer, B. A., Schuetz, A., Grandin, P. V., O'Connell, R. J., Ledgerwood, J. E., Graham, B. S., Tressler, R., Mascola, J. R., Chomont, N., Michael, N. L., Robb, M. L., Phanuphak, N., and Ananworanich, J., Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial., Lancet HIV, vol. 6, no. 5, pp. e297-e306, 2019.
P. K. Ehrenberg, Shangguan, S., Issac, B., Alter, G., Geretz, A., Izumi, T., Bryant, C., Eller, M. A., Wegmann, F., Apps, R., Creegan, M., Bolton, D. L., Sekaly, R. P., Robb, M. L., Gramzinski, R. A., Pau, M. G., Schuitemaker, H., Barouch, D. H., Michael, N. L., and Thomas, R., A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials., Sci Transl Med, vol. 11, no. 507, 2019.